Рет қаралды 33,588
Spike S1 Persists Up To 245 Days in Vaccinated Individuals - New Study (Preprint)
The following study is a preprint by Dr. Bruce Patterson and his team. In this small study Dr. Patterson et. al find that the individuals suffering from long COVID like symptoms after vaccination have persistent spike protein S1, S2, and even a mutant S1 in their non-classical and intermediate (CD16+) monocytes. These monocytes have an affinity to bind with the blood vessel endothelium. Hence, vascular damage/inflammation and clotting will ensue.
Management approach they offer is CCR5 antagonists (like Maraviroc) and Statins to reduce the binding of CD16+ monocytes to endothelium.
If you like this content and want more, I am doing a special one coffee a month membership offer. Get it before this offer is gone: www.drbeen.com/med-nerd/
Want to support this work?:
Buy me a coffee :-) www.buymeacoffee.com/DrMobeen...
Become my patron: www.patreon.com/mobeensyed?fa...
My substack: mobeensyedmd.substack.com/
#drbeen #koolbeens #COVID
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Reference:
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms | medRxiv
www.medrxiv.org/content/10.11...